- Home
- CEAD vs GLMD Comparison
CEAD vs GLMD Comparison
Compare CEAD & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEAD
- GLMD
- Stock Information
- Founded
- CEAD 2009
- GLMD 2000
- Country
- CEAD United States
- GLMD Israel
- Employees
- CEAD N/A
- GLMD N/A
- Industry
- CEAD Industrial Machinery/Components
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- CEAD Industrials
- GLMD Health Care
- Exchange
- CEAD Nasdaq
- GLMD Nasdaq
- Market Cap
- CEAD 5.6M
- GLMD 5.9M
- IPO Year
- CEAD N/A
- GLMD 2014
- Fundamental
- Price
- CEAD $7.04
- GLMD $4.68
- Analyst Decision
- CEAD
- GLMD
- Analyst Count
- CEAD 0
- GLMD 0
- Target Price
- CEAD N/A
- GLMD N/A
- AVG Volume (30 Days)
- CEAD 8.3K
- GLMD 264.1K
- Earning Date
- CEAD 11-12-2024
- GLMD 11-20-2024
- Dividend Yield
- CEAD N/A
- GLMD N/A
- EPS Growth
- CEAD N/A
- GLMD N/A
- EPS
- CEAD N/A
- GLMD N/A
- Revenue
- CEAD $3,159,870.00
- GLMD N/A
- Revenue This Year
- CEAD N/A
- GLMD N/A
- Revenue Next Year
- CEAD N/A
- GLMD N/A
- P/E Ratio
- CEAD N/A
- GLMD N/A
- Revenue Growth
- CEAD N/A
- GLMD N/A
- 52 Week Low
- CEAD $5.22
- GLMD $2.73
- 52 Week High
- CEAD $11.04
- GLMD $23.80
- Technical
- Relative Strength Index (RSI)
- CEAD 52.75
- GLMD 49.78
- Support Level
- CEAD $6.87
- GLMD $3.40
- Resistance Level
- CEAD $7.26
- GLMD $4.15
- Average True Range (ATR)
- CEAD 0.25
- GLMD 0.51
- MACD
- CEAD 0.00
- GLMD -0.11
- Stochastic Oscillator
- CEAD 61.18
- GLMD 55.17
About CEAD CEA Industries Inc.
CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.